The European Commission issued a corrigendum on 16 July 2026 correcting three errors in Regulation (EU) 2026/78, which amends the EU Cosmetics Regulation (EC) No 1223/2009 regarding the use of certain carcinogenic, mutagenic, or reprotoxic (CMR) substances in cosmetic products. The corrections replace the Spanish term "plata maciza" with "plata masiva" in three specific locations of the regulation, affecting the description of silver substances.
The corrigendum, published as C(2026)5265, addresses errors in recital 7, recital 11, and the Annex of Regulation (EU) 2026/78, which was adopted on 12 January 2026 and published in the Official Journal on 13 January 2026. The original regulation introduced restrictions on silver in various forms—bulk, powder, and nanoparticles—classified as a category 2 CMR substance, and amended entry 1727 of Annex II of the Cosmetics Regulation. The corrections are purely linguistic and do not alter the regulatory substance or scope of the original act.
Regulation (EU) 2026/78 is part of the EU's ongoing efforts to align cosmetics rules with the latest scientific evidence on CMR substances, restricting or prohibiting their use in cosmetic products to protect consumer health. The corrigendum ensures the Spanish language version of the regulation accurately reflects the intended terminology for silver in bulk form, which is relevant for manufacturers, importers, and distributors of cosmetic products containing silver ingredients.
The corrigendum does not introduce new obligations or modify the compliance timeline for stakeholders. The original regulation remains in force, and the corrected text applies retroactively from the date of the original regulation's entry into force. The European Commission has not indicated any further amendments to the cosmetics regulation related to CMR substances at this time.